00000000|MMI|19.26|Angioedemas, Hereditary|C0019243|[dsyn]|["Hereditary angio oedema"-tx-1-"hereditary angioedema"-noun-0]|TX|64/21|C14.907.079.500;C16.320.078;C17.800.862.945.066.500;C20.543.480.904.066.500
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|123/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.49|SERPING1 gene|C1412922|[gngm]|["angioedema, hereditary"-tx-1-"hereditary angioedema"-noun-0]|TX|64/21|
00000000|MMI|3.46|10%|C3842590|[fndg]|["10%"-tx-1-"10"-fraction-0]|TX|112/2|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|90/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|90/3|
00000000|MMI|154.47|Portugal|C0032729|[geoa]|["PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0]|TX|1748/2;1626/2;1299/2;[406/2],[572/2],[704/2],[842/2],[991/2],[1026/2],[1059/2],[1155/2]|Z01.542.727
00000000|MMI|144.82|Digoxin|C0012265|[orch,phsu]|["DIGOXIN"-tx-7-"DIGOXIN"-noun-0,"DIGOXIN"-tx-5-"DIGOXIN"-noun-0]|TX|[1409/7],[1477/7];[455/7],[627/7],[687/7],[897/7]|D04.808.155.580.130.500.436;D04.808.155.580.130.688;D09.408.180.261.436
00000000|MMI|101.63|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Patient Discharge"-tx-3-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5079/9;4929/9;2158/9;146/17;33/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|85.09|Danazol|C0010961|[horm,orch,phsu]|["DANAZOL"-tx-38-"danazol"-noun-0,"DANAZOL"-tx-34-"danazol"-noun-0,"DANAZOL"-tx-13-"danazol"-noun-0,"DANAZOL"-tx-11-"danazol"-noun-0,"DANAZOL"-tx-5-"DANAZOL"-noun-0]|TX|4675/7;4313/7;3175/7;2923/7;433/7|D04.808.745.432.235
00000000|MMI|84.84|Levothyroxine Sodium|C0079691|[aapp,horm,phsu]|["Laevothyroxine sodium"-tx-7-"LEVOTHYROXINE SODIUM"-noun-0,"Laevothyroxine sodium"-tx-6-"LEVOTHYROXINE SODIUM"-noun-0,"Laevothyroxine sodium"-tx-5-"LEVOTHYROXINE SODIUM"-noun-0]|TX|[1423/20],[1491/20];1269/20;[641/20],[911/20]|D06.472.931.812;D12.125.072.050.767
00000000|MMI|84.84|Fluorides|C0016327|[inch,phsu]|["F-"-tx-41-"F"-noun-0,"F-"-tx-41-"f"-noun-0,"F-"-tx-40-"f"-noun-0,"F-"-tx-32-"F"-noun-0,"F-"-tx-3-"F"-noun-0]|TX|5020/1;4801/1;4761/1;4144/1;293/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|83.50|Mongolia|C0026410|[geoa]|["MG"-tx-8-"MG"-noun-0,"MG"-tx-7-"MG"-noun-0,"MG"-tx-5-"MG"-noun-0]|TX|1745/2;1623/2;[701/2],[988/2],[1023/2],[1056/2]|Z01.252.474.651
00000000|MMI|79.55|Angioedemas, Hereditary|C0019243|[dsyn]|["Hereditary angio oedema"-tx-9-"HEREDITARY ANGIOEDEMA"-noun-0,"Hereditary angio oedema"-tx-9-"hereditary angioedema"-noun-0]|TX|2332/21;[2126/21],[2227/21],[2650/21]|C14.907.079.500;C16.320.078;C17.800.862.945.066.500;C20.543.480.904.066.500
00000000|MMI|79.53|Override|C1547671|[acty]|["Override"-tx-7-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"overridden"-noun-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"overridden"-noun-0,"Override"-tx-5-"override"-verb-0]|TX|1523/8;1323/8;1311/10;1243/8;[479/8],[496/8],[749/8],[766/8],[1083/8];1071/10;[673/8],[943/8]|
00000000|MMI|79.39|3,4-Methylenedioxyamphetamine|C0000379|[orch,phsu]|["MDA"-tx-7-"mda"-noun-0,"MDA"-tx-6-"mda"-noun-0,"MDA"-tx-5-"mda"-noun-0]|TX|1533/3;1253/3;[683/3],[953/3]|D02.092.471.683.152.660
00000000|MMI|66.91|Dominican Republic|C0013014|[geoa]|["DR"-tx-40-"Dr"-noun-0,"DR"-tx-14-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-2-"Dr"-noun-0]|TX|4780/2;3305/2;1838/2;95/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|58.03|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-9-"ASA"-noun-0,"ASPIRIN"-tx-5-"ASPIRIN"-noun-0]|TX|2373/3;375/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|54.60|Oral|C0442027|[spco]|["PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0]|TX|1748/2;1626/2;1299/2;[406/2],[572/2],[704/2],[842/2],[991/2],[1026/2],[1059/2],[1155/2]|
00000000|MMI|53.91|Physicians|C0031831|[prog]|["DR"-tx-40-"Dr"-noun-0,"DR"-tx-14-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-2-"Dr"-noun-0]|TX|4780/2;3305/2;1838/2;95/2|M01.526.485.810;N02.360.810
00000000|MMI|53.39|Moldova|C0026374|[geoa]|["MDA"-tx-7-"mda"-noun-0,"MDA"-tx-6-"mda"-noun-0,"MDA"-tx-5-"mda"-noun-0]|TX|1533/3;1253/3;[683/3],[953/3]|Z01.542.248.540;Z01.586.200.540;Z01.586.950.540
00000000|MMI|52.12|C1 esterase inhibitor|C0540301|[aapp,bacs,phsu]|["C1 Esterase Inhibitor"-tx-35-"C1 esterase inhibitor"-noun-0,"C1 Esterase Inhibitor"-tx-30-"c1 esterase inhibitor"-noun-0]|TX|4411/21;4065/21|D12.644.861.140.500;D12.776.124.486.274.920.250.500;D12.776.395.320;D12.776.872.140.500
00000000|MMI|49.09|Synthroid|C0728762|[aapp,phsu]|["Synthroid"-tx-6-"SYNTHROID"-noun-0,"Synthroid"-tx-5-"SYNTHROID"-noun-0]|TX|1257/9;[562/9],[832/9]|D06.472.931.812;D12.125.072.050.767
00000000|MMI|49.05|Ivory Coast|C0022326|[geoa]|["IV"-tx-36-"IV"-noun-0,"IV"-tx-17-"IV"-noun-0,"IV"-tx-9-"IV"-noun-0]|TX|4462/2;3574/2;1922/2|Z01.058.290.190.272
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2115/9],[2255/9]|x.x.x.x.x.x.x
00000000|MMI|45.77|Complement C1 Inactivator Proteins|C0009500|[aapp,imft,phsu]|["c1-esterase inhibitor"-tx-35-"C1 esterase inhibitor"-noun-0,"c1-esterase inhibitor"-tx-30-"c1 esterase inhibitor"-noun-0]|TX|4411/21;4065/21|D12.644.861.140;D12.776.124.486.274.920.250;D12.776.872.140
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-5-"CODE"-noun-0,"code"-tx-5-"code"-noun-0]|TX|303/4;321/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|38.78|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-5-"LASIX"-noun-0]|TX|[1032/5],[1149/5]|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|35.81|Togo|C0040363|[geoa]|["TO"-tx-36-"to"-adv-0,"TO"-tx-15-"to"-adv-0]|TX|4471/2;3399/2|Z01.058.290.190.800
00000000|MMI|35.81|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-36-"to"-adv-0,"TO"-tx-15-"to"-adv-0]|TX|4471/2;3399/2|D08.811.520.224.800
00000000|MMI|33.49|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-42-"M.D"-noun-0,"M.D."-tx-6-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0]|TX|5025/3;1371/3;[544/3],[814/3],[1131/3];298/3|
00000000|MMI|32.46|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-16-"DVT"-noun-0,"DVT NOS"-tx-9-"DVT"-noun-0]|TX|3465/3;2461/3|C14.907.355.830.925
00000000|MMI|32.40|Angioedema|C0002994|[patf]|["Angiooedema"-tx-32-"angioedema"-noun-0,"Angiooedema"-tx-13-"angioedema"-noun-0]|TX|4162/10;3149/10|C14.907.079;C17.800.862.945.066;C20.543.480.904.066
00000000|MMI|30.42|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-7-"grapefruit"-noun-0]|TX|1673/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|29.88|Edema|C0013604|[fndg]|["SWELLING"-tx-22-"swelling"-noun-1,"SWELLING"-tx-10-"swelling"-noun-0,"OEDEMA"-tx-9-"edema"-noun-0]|TX|3832/8;2841/8;2728/5|C23.888.277
00000000|MMI|27.01|Daily|C0332173|[tmco]|["QD"-tx-18-"QD"-noun-0,"/day"-tx-15-"day"-noun-0,"QD"-tx-8-"QD"-noun-0,"QD"-tx-6-"QD"-noun-0,"QD"-tx-5-"QD"-noun-0]|TX|3630/2;3366/3;1751/2;1302/2;[409/2],[1029/2],[1062/2]|
00000000|MMI|26.44|Contrast Media|C0009924|[irda]|["Contrast"-tx-17-"contrast"-noun-0,"Contrast"-tx-9-"Contrast"-noun-0]|TX|3577/8;1925/8|D27.505.259.500;D27.720.259
00000000|MMI|26.30|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-16-"afib"-noun-0,"AFib"-tx-9-"AFIB"-noun-0]|TX|3498/4;2354/4|C14.280.067.198;C23.550.073.198
00000000|MMI|26.14|Panama|C0030266|[geoa]|["PM"-tx-44-"PM"-noun-0,"PM"-tx-3-"PM"-adj-0]|TX|5062/2;185/2|Z01.107.169.772
00000000|MMI|25.41|Patients|C0030705|[podg]|["*^patient"-tx-33-"Patient"-noun-0,"*^patient"-tx-14-"patient"-noun-0,"*^patient"-tx-12-"Patient"-noun-0]|TX|4205/7;3228/7;2959/7|M01.643
00000000|MMI|24.11|Levaquin|C0721336|[orch,phsu]|["Levaquin"-tx-17-"levaquin"-noun-0]|TX|3594/8|D03.438.810.835.322.500.500
00000000|MMI|24.11|Levofloxacin|C0282386|[antb,orch]|["LEVOFLOXACIN"-tx-9-"LEVOFLOXACIN"-noun-0]|TX|1978/12|D03.438.810.835.322.500.500
00000000|MMI|24.11|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-9-"Penicillins"-noun-0]|TX|1944/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|24.11|Syncope|C0039070|[sosy]|["FAINT"-tx-26-"Faint"-noun-0]|TX|3941/5|C10.597.606.358.800.600;C23.888.592.604.359.800.600
00000000|MMI|23.69|Order (action)|C1705178|[acty]|["Order"-tx-44-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.69|Order (arrangement)|C1705176|[qlco]|["Order"-tx-44-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.69|Order (document)|C1705175|[inpr]|["Order"-tx-44-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.69|Order (taxonomic)|C1705177|[clas]|["Order"-tx-44-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.69|Permutation|C1882348|[qlco]|["Order"-tx-44-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.69|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-44-"ORDERS"-verb-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-3-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5089/6;[552/5],[822/5],[1139/5];228/5;43/6|
00000000|MMI|23.20|Hospital admission|C0184666|[hlca]|["admitted"-tx-33-"admitted"-verb-0,"Admission"-tx-15-"admission"-noun-0,"Admission"-tx-12-"admission"-noun-0,"Admission"-tx-9-"Admission"-noun-0,"Admit"-tx-9-"ADMIT"-verb-0,"admitted"-tx-9-"admitted"-verb-0]|TX|4217/8;3373/9;2980/9;2215/9;2109/5;2739/8|
00000000|MMI|23.12|Exanthema|C0015230|[sosy]|["Rashes"-tx-27-"rashes"-noun-1,"RASH"-tx-5-"RASH"-noun-0]|TX|3969/6;1226/4|C17.800.257
00000000|MMI|22.51|Benadryl|C0700899|[orch,phsu]|["Benadryl"-tx-34-"benadryl"-noun-0]|TX|4386/8|D02.092.471.320;D02.455.426.559.389.115.250
00000000|MMI|22.48|Unmarried|C0087136|[fndg]|["single"-tx-36-"single"-adj-0]|TX|4447/6|F01.829.263.315.500.725;I01.240.361.500.725;I01.880.853.150.423.500.725;M01.785;N01.224.361.500.725;N01.824.308.500.725
00000000|MMI|22.48|Unmarried person|C0037179|[popg]|["Single"-tx-36-"single"-adj-0]|TX|4447/6|F01.829.263.315.500.725;I01.240.361.500.725;I01.880.853.150.423.500.725;M01.785;N01.224.361.500.725;N01.824.308.500.725
00000000|MMI|22.37|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-9-"ASA"-noun-0]|TX|2373/3|D08.811.277.352.827.070.250
00000000|MMI|22.37|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|x.x.x.x.x.x.x
00000000|MMI|22.35|colonoscopy|C0009378|[diap]|["Colonoscopy"-tx-12-"colonoscopy"-noun-0]|TX|3021/11|E01.370.372.250.250.200;E01.370.388.250.250.250.160;E04.210.240.250.160;E04.502.250.250.250.160
00000000|MMI|22.34|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-8-"MG"-noun-0,"Mg++"-tx-7-"MG"-noun-0,"Mg++"-tx-5-"MG"-noun-0]|TX|1745/2;1623/2;[701/2],[988/2],[1023/2],[1056/2]|
00000000|MMI|22.34|Milligram percent|C1960952|[qnco]|["mg %"-tx-8-"MG"-noun-0,"mg %"-tx-7-"MG"-noun-0,"mg %"-tx-5-"MG"-noun-0]|TX|1745/2;1623/2;[701/2],[988/2],[1023/2],[1056/2]|
00000000|MMI|22.34|mg/dL|C0439269|[qnco]|["mg%"-tx-8-"MG"-noun-0,"mg%"-tx-7-"MG"-noun-0,"mg%"-tx-5-"MG"-noun-0]|TX|1745/2;1623/2;[701/2],[988/2],[1023/2],[1056/2]|
00000000|MMI|20.95|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-5-"DOCUSATE SODIUM"-noun-0]|TX|966/15|D02.241.081.337.759.249
00000000|MMI|20.95|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-5-"FUROSEMIDE"-noun-0]|TX|1040/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|20.19|Disease|C0012634|[dsyn]|["condition"-tx-41-"CONDITION"-noun-0,"condition"-tx-9-"Conditions"-noun-0]|TX|4939/9;2265/10|C23.550.288
00000000|MMI|19.72|Tracheostomy procedure|C0040590|[topp]|["Tracheostomies"-tx-9-"tracheostomies"-noun-0]|TX|[2421/14],[2699/14]|E02.041.750;E04.579.935;E04.580.900;E04.928.780
00000000|MMI|19.45|Colace|C0282139|[orch,phsu]|["Colace"-tx-5-"COLACE"-noun-0]|TX|957/6|D02.241.081.337.759.249
00000000|MMI|19.45|Complete Blood Count|C0009555|[lbpr]|["CBC"-tx-29-"CBC"-noun-0]|TX|4035/3|E01.370.225.500.195.107;E01.370.225.625.107;E05.200.500.195.107;E05.200.625.107;E05.242.195.107;G04.170.107;G09.188.105
00000000|MMI|19.45|Connecticut|C0009778|[geoa]|["Connecticut"-tx-9-"Connecticut"-noun-0]|TX|1889/11|Z01.107.567.875.550.200
00000000|MMI|19.45|Rhinocort|C0678163|[orch,phsu]|["Rhinocort"-tx-7-"RHINOCORT"-noun-0]|TX|1537/9|D04.808.745.745.654.105
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-3-"D/C"-noun-0]|TX|224/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.22|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-5-"ATENOLOL"-noun-0]|TX|412/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|19.21|Complement component C5|C0009519|[aapp,imft]|["Complement 5"-tx-41-"5 complement"-noun-0]|TX|4794/1,4805/10|D12.776.124.486.274.450
00000000|MMI|19.19|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-9-"GERD"-noun-0]|TX|2487/4|C06.405.117.119.500.484
00000000|MMI|18.64|Admission activity|C0809949|[hlca]|["Admitted"-tx-33-"admitted"-verb-0,"Admission"-tx-15-"admission"-noun-0,"Admission"-tx-12-"admission"-noun-0,"Admission"-tx-9-"Admission"-noun-0,"Admitted"-tx-9-"admitted"-verb-0]|TX|4217/8;3373/9;2980/9;2215/9;2739/8|
00000000|MMI|17.80|Famotidine|C0015620|[orch,phsu]|["FAMOTIDINE"-tx-5-"FAMOTIDINE"-noun-0]|TX|1007/10|D02.886.675.215;D03.383.129.708.215
00000000|MMI|17.80|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-9-"LISINOPRIL"-noun-0]|TX|1993/10|D12.644.456.345.600
00000000|MMI|17.80|Nitrofurantoin|C0028156|[orch,phsu]|["NITROFURANTOIN"-tx-9-"NITROFURANTOIN"-noun-0]|TX|2006/14|D02.640.600.566;D03.383.312.649.566
00000000|MMI|16.25|Abdominal Pain|C0000737|[sosy]|["ABDOMINAL PAIN"-tx-10-"abdominal pain"-noun-0]|TX|2855/14|C10.597.617.044;C23.888.592.612.054;C23.888.821.030
00000000|MMI|16.25|Blood coagulation tests|C0005790|[lbpr]|["Coag"-tx-29-"coags"-noun-0]|TX|4048/5|E01.370.225.625.115;E05.200.625.115
00000000|MMI|16.22|Pepcid|C0678119|[orch,phsu]|["Pepcid"-tx-5-"PEPCID"-noun-0]|TX|998/6|D02.886.675.215;D03.383.129.708.215
00000000|MMI|16.21|Subdural space|C0038541|[bsoj]|["Subdural"-tx-9-"SUBDURAL"-adj-0]|TX|2389/8|A08.186.566.395.687
00000000|MMI|16.16|Patient observation|C0700325|[hlca]|["Observation"-tx-33-"observation"-noun-0]|TX|4237/11|N04.761.559.590.900
00000000|MMI|16.12|Uvula of palate|C0042173|[bpoc]|["Uvula"-tx-22-"uvula"-noun-0]|TX|3826/5|A14.549.617.780.729
00000000|MMI|16.10|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-7-"Food/Drug Interaction"-noun-0]|TX|1633/21|G07.690.773.968.511
00000000|MMI|16.04|Iodides|C0021966|[inch]|["I-"-tx-36-"I"-noun-0]|TX|4483/1|D01.248.497.158.490;D01.475.410
00000000|MMI|15.79|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-33-"Patient"-noun-0,"Patient"-tx-14-"patient"-noun-0,"Patient"-tx-12-"Patient"-noun-0]|TX|4205/7;3228/7;2959/7|
00000000|MMI|15.79|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-33-"Patient"-noun-0,"Patient"-tx-14-"patient"-noun-0,"Patient"-tx-12-"Patient"-noun-0]|TX|4205/7;3228/7;2959/7|
00000000|MMI|15.79|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-33-"Patient"-noun-0,"Patient"-tx-14-"patient"-noun-0,"Patient"-tx-12-"Patient"-noun-0]|TX|4205/7;3228/7;2959/7|
00000000|MMI|15.21|Lip swelling|C0240211|[sosy]|["LIP SWELLING"-tx-41-"lip swelling"-noun-0,"LIP SWELLING"-tx-32-"lip swelling"-noun-0,"Swelling of lip"-tx-15-"lip swelling of"-noun-0,"LIP SWELLING"-tx-9-"lip swelling"-noun-0]|TX|4892/12;4191/12;3350/12,3370/2;2753/12|
00000000|MMI|14.94|Interaction|C1704675|[ftcn]|["Interaction"-tx-7-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0]|TX|[1396/11],[1464/11];[614/11],[884/11]|
00000000|MMI|14.90|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-40-"Dr"-noun-0,"DR"-tx-14-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-2-"Dr"-noun-0]|TX|4780/2;3305/2;1838/2;95/2|
00000000|MMI|14.90|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-40-"Dr"-noun-0,"DR"-tx-14-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-2-"Dr"-noun-0]|TX|4780/2;3305/2;1838/2;95/2|
00000000|MMI|14.90|Doctor - Title|C2348314|[cnce]|["Dr."-tx-40-"Dr"-noun-0,"Dr."-tx-14-"Dr"-noun-0,"Dr."-tx-8-"Dr"-noun-0,"Dr."-tx-2-"Dr"-noun-0]|TX|4780/2;3305/2;1838/2;95/2|
00000000|MMI|14.77|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-7-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0]|TX|1512/6;1232/6;[662/6],[932/6]|
00000000|MMI|14.70|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5079/9;4929/9;2158/9;33/9|
00000000|MMI|14.70|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5079/9;4929/9;2158/9;33/9|
00000000|MMI|14.67|Additional|C1524062|[ftcn]|["Added"-tx-6-"added"-verb-0,"Added"-tx-5-"added"-verb-0]|TX|1332/5;[505/5],[775/5],[1092/5]|
00000000|MMI|14.64|Dairy Products|C0010947|[food]|["Dairy Products"-tx-9-"Dairy Products"-noun-0]|TX|2049/14|G07.203.300.350;J02.500.350
00000000|MMI|14.64|Quinidine Sulfate|C0034415|[orch,phsu]|["Quinidine sulphate"-tx-9-"QUINIDINE SULFATE"-noun-0]|TX|1958/17|D03.132.206.636;D03.438.810.699;D03.605.687.637
00000000|MMI|14.64|Ranitidine Hydrochloride|C0700466|[orch,phsu]|["Ranitidine.HCl"-tx-8-"RANITIDINE HCL"-noun-0]|TX|1724/14|D03.383.312.750
00000000|MMI|14.64|Stridor|C0038450|[sosy]|["STRIDOR"-tx-23-"stridor"-noun-1]|TX|3851/7|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|14.64|Zantac|C0592278|[orch,phsu]|["Zantac"-tx-8-"ZANTAC"-noun-0]|TX|1715/6|D03.383.312.750
00000000|MMI|14.54|SERPING1 gene|C1412922|[gngm]|["angioedema, hereditary"-tx-9-"HEREDITARY ANGIOEDEMA"-noun-0,"angioedema, hereditary"-tx-9-"hereditary angioedema"-noun-0]|TX|2332/21;[2126/21],[2227/21],[2650/21]|
00000000|MMI|14.31|Serious|C0205404|[qlco]|["Serious"-tx-7-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0]|TX|[1388/7],[1456/7];[606/7],[876/7]|
00000000|MMI|13.59|Hypersensitivity|C0020517|[patf]|["Allergies"-tx-17-"allergies"-noun-0,"ALLERGY"-tx-9-"ALLERGY"-noun-0]|TX|3554/9;1913/7|C20.543
00000000|MMI|13.10|Ability|C0085732|[orga]|["Able"-tx-20-"able"-adj-0]|TX|3710/4|F02.784.629.131
00000000|MMI|13.09|Solomon Islands|C0037623|[geoa]|["BP"-tx-19-"bp"-noun-0]|TX|3665/2|Z01.639.760.590
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-41-"PLAN"-noun-0]|TX|4963/4|C10.228.140.744
00000000|MMI|13.07|Diet|C0012155|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|1754/4|G07.203.650.240
00000000|MMI|13.05|Rales|C0034642|[sosy]|["Crackles"-tx-26-"crackles"-verb-0]|TX|3947/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|13.03|Rabbi|C0684010|[prog]|["R."-tx-9-"R"-noun-0]|TX|2576/1|M01.526.799.500
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-3-"D/C"-noun-0]|TX|224/3|E04.157.310;E04.950.300.299
00000000|MMI|12.96|Dyspnea|C0013404|[sosy]|["DIFFICULTY BREATHING"-tx-41-"difficulty breathing"-noun-0]|TX|4908/20|C08.618.326;C23.888.852.371
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-3-"CAR"-noun-0]|TX|142/3|J01.937.500.100
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-9-"ALLERGY"-noun-0]|TX|1913/7|H02.403.044
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-9-"Complications"-noun-0]|TX|2291/13|x.x.x
00000000|MMI|11.49|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-16-"HTN"-noun-0]|TX|3492/3|C14.907.489
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-9-"PROCEDURES"-noun-0]|TX|2520/10|x.x.x
00000000|MMI|11.49|Stenosis|C1261287|[patf]|["Stricture"-tx-12-"stricture"-noun-0]|TX|3053/9|C23.300.287
00000000|MMI|11.49|Thinking, function|C0039869|[menp]|["Thought"-tx-13-"thought"-verb-0]|TX|3124/7|F02.463.785
00000000|MMI|11.22|Fresh frozen plasma|C0016709|[bdsu]|["FFP"-tx-36-"FFP"-noun-0,"FFP"-tx-35-"FFP"-noun-0,"FFP"-tx-34-"FFP"-noun-0]|TX|4501/3;4398/3;4344/3|
00000000|MMI|11.22|ALYREF gene|C1425988|[gngm]|["REF"-tx-5-"ref"-noun-0]|TX|[577/3],[847/3],[1160/3]|
00000000|MMI|10.65|Clinical immunologist|C0334896|[prog]|["Allergist"-tx-40-"allergist"-noun-0,"Allergist"-tx-38-"allergist"-noun-0,"Allergist"-tx-14-"Allergist"-noun-0]|TX|4770/9;4630/9;3295/9|
00000000|MMI|10.58|Due to|C0678226|[ftcn]|["Due To"-tx-13-"due to"-prep-0,"Due To"-tx-9-"due to"-prep-0,"due"-tx-9-"due"-prep-0]|TX|3139/6;2714/6;2714/3|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2115/9],[2255/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2115/9],[2255/9]|
00000000|MMI|10.42|Including (qualifier)|C0332257|[ftcn]|["include"-tx-18-"include"-verb-0,"Including"-tx-17-"including"-verb-0]|TX|3609/7;3564/9|
00000000|MMI|10.42|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-15-"now"-adv-0,"Now"-tx-9-"now"-adv-0]|TX|3330/3;2735/3|
00000000|MMI|10.42|To|C1883351|[qlco]|["To"-tx-36-"to"-adv-0,"To"-tx-15-"to"-adv-0]|TX|4471/2;3399/2|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-44-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5089/6;43/6|
00000000|MMI|9.94|Institutes|C0021622|[orgt]|["institute"-tx-39-"instituting"-verb-0]|TX|4718/11|N03.540.052
00000000|MMI|9.91|Diet therapy|C0012159|[hlca]|["Diet"-tx-8-"DIET"-noun-0]|TX|1754/4|E02.642.249
00000000|MMI|9.91|Abdomen|C0000726|[blor]|["Abdominal"-tx-10-"abdominal"-noun-0]|TX|2855/9|A01.923.047
00000000|MMI|9.91|Appointments|C0003629|[idcn]|["Appointment"-tx-8-"APPOINTMENT"-noun-0]|TX|1820/11|N04.452.095
00000000|MMI|9.88|Filtering Surgery|C0242673|[topp]|["filter operations"-tx-9-"filter OPERATIONS"-noun-0]|TX|2471/6,2505/10|E04.540.450
00000000|MMI|9.86|Observation in research|C0302523|[resa]|["Observation"-tx-33-"observation"-noun-0]|TX|4237/11|E05.581.249
00000000|MMI|9.76|Intestines|C0021853|[bpoc]|["Bowel"-tx-10-"bowel"-noun-0]|TX|2835/5|A03.556.124
00000000|MMI|9.75|Hospitals|C0019994|[hcro,mnob]|["HOSPITAL"-tx-41-"hospital"-noun-0]|TX|4865/8|N02.278.421
00000000|MMI|9.73|Polycythemia|C0032461|[dsyn]|["POLYCYTHEMIA"-tx-9-"polycythemia"-noun-0]|TX|2492/12|C15.378.738
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-9-"ALLERGY"-noun-0]|TX|1913/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-9-"Infections"-noun-0]|TX|2278/10|C01.539
00000000|MMI|8.34|Lung|C0024109|[bpoc]|["LUNGS"-tx-24-"Lungs"-noun-0]|TX|3885/5|A04.411
00000000|MMI|8.34|Maintenance|C0024501|[acty]|["Maintain"-tx-36-"maintain"-verb-0]|TX|4474/8|N02.628
00000000|MMI|8.00|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-27-"noted"-verb-0,"Note"-tx-22-"noted"-verb-0]|TX|3976/5;3841/5|
00000000|MMI|8.00|Note (document)|C1317574|[inpr]|["Note"-tx-27-"noted"-verb-0,"Note"-tx-22-"noted"-verb-0]|TX|3976/5;3841/5|
00000000|MMI|7.70|C>1<q esterase inhibitor|C1443212|[aapp,bacs]|["C 1 Esterase inhibitor"-tx-35-"C1 esterase inhibitor"-noun-0,"C 1 Esterase inhibitor"-tx-30-"c1 esterase inhibitor"-noun-0]|TX|4411/21;4065/21|
00000000|MMI|7.50|Condition|C0348080|[qlco]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4939/9;2265/10|
00000000|MMI|7.50|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4939/9;2265/10|
00000000|MMI|7.50|Logical Condition|C1705253|[cnce]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4939/9;2265/10|
00000000|MMI|7.40|Contrast|C1979874|[qlco]|["Contrast"-tx-17-"contrast"-noun-0,"Contrast"-tx-9-"Contrast"-noun-0]|TX|3577/8;1925/8|
00000000|MMI|7.35|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-13-"symptoms"-noun-0,"SYMPTOMS"-tx-10-"symptoms"-noun-0]|TX|3104/8;2797/8|
00000000|MMI|7.35|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-13-"symptoms"-noun-0,"symptoms"-tx-10-"symptoms"-noun-0]|TX|3104/8;2797/8|
00000000|MMI|7.35|year|C0439234|[tmco]|["YEARS"-tx-11-"years"-noun-0,"YEARS"-tx-10-"years"-noun-0]|TX|2952/5;2777/5|
00000000|MMI|7.31|80%|C3842583|[fndg]|["80%"-tx-19-"80"-fraction-0,"80%"-tx-19-"80s"-noun-0]|TX|3672/2;3680/3|
00000000|MMI|7.29|Not Applicable|C1272460|[qlco]|["{NA}"-tx-7-"NA"-noun-0,"NOT APPLICABLE"-tx-3-"Not Applicable"-adj-0]|TX|1584/2;204/14|
00000000|MMI|7.29|Package Type Not Applicable|C4049872|[ftcn]|["NA"-tx-7-"NA"-noun-0,"Not Applicable"-tx-3-"Not Applicable"-adj-0]|TX|1584/2;204/14|
00000000|MMI|7.27|Alternate days|C0558287|[tmco]|["QOD"-tx-5-"QOD"-adv-0]|TX|[475/3],[707/3]|
00000000|MMI|7.27|Room of building - Study|C0557651|[mnob]|["Study"-tx-41-"studies"-verb-0,"Study"-tx-9-"Study"-noun-0]|TX|4822/7;2197/5|
00000000|MMI|7.27|Study|C2603343|[resa]|["Study"-tx-41-"studies"-verb-0,"Study"-tx-9-"Study"-noun-0]|TX|4822/7;2197/5|
00000000|MMI|7.27|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AFib"-tx-16-"afib"-noun-0,"AFib"-tx-9-"AFIB"-noun-0]|TX|3498/4;2354/4|
00000000|MMI|7.26|Status|C0449438|[qlco]|["Status"-tx-36-"status"-noun-0,"Status"-tx-5-"STATUS"-noun-0]|TX|4487/6;308/6|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-41-"summary"-noun-0,"Summary"-tx-3-"SUMMARY"-noun-0]|TX|4981/7;253/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-41-"summary"-noun-0,"summary"-tx-3-"SUMMARY"-noun-0]|TX|4981/7;253/7|
00000000|MMI|7.23|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-7-"Instruction"-noun-0,"instructions"-tx-5-"Instructions"-noun-0]|TX|1655/11;711/12|
00000000|MMI|7.23|Instructions|C1442085|[idcn]|["instruction"-tx-7-"Instruction"-noun-0,"Instructions"-tx-5-"Instructions"-noun-0]|TX|1655/11;711/12|
00000000|MMI|7.21|S prime|C2603362|[clna]|["S'"-tx-9-"s"-prep-0,"S'"-tx-8-"("-noun-0]|TX|2673/1;1831/1|
00000000|MMI|7.21|per second|C0565930|[qnco]|["/s"-tx-9-"s"-prep-0,"/s"-tx-8-"("-noun-0]|TX|2673/1;1831/1|
00000000|MMI|7.19|High dose|C0444956|[qnco]|["High dose"-tx-38-"higher dose"-noun-0,"High dose"-tx-34-"higher dose"-noun-0]|TX|4660/11;4301/11|
00000000|MMI|7.16|Hospital course|C0489547|[fndg]|["Hospital course"-tx-31-"Hospital course"-noun-0,"Hospital course"-tx-9-"HOSPITAL COURSE"-noun-1]|TX|4119/15;2602/15|
00000000|MMI|7.16|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-31-"Hospital course"-noun-0,"Hospital course"-tx-9-"HOSPITAL COURSE"-noun-0]|TX|4119/15;2602/15|
00000000|MMI|7.13|Swelling|C0038999|[fndg]|["SWELLING"-tx-22-"swelling"-noun-1,"SWELLING"-tx-10-"swelling"-noun-0]|TX|3832/8;2841/8|
00000000|MMI|7.12|Three times daily|C0556984|[tmco]|["TID"-tx-34-"tid"-noun-0,"TID"-tx-5-"TID"-noun-0]|TX|4327/3;451/3|
00000000|MMI|7.12|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-34-"tid"-noun-0,"TID"-tx-5-"TID"-noun-0]|TX|4327/3;451/3|
00000000|MMI|7.11|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-44-"PM"-noun-0,"PM"-tx-3-"PM"-adj-0]|TX|5062/2;185/2|
00000000|MMI|7.11|Increase|C0442805|[ftcn]|["Increased"-tx-23-"increased"-adj-0,"Increased"-tx-13-"increased"-verb-0]|TX|3862/9;3187/9|
00000000|MMI|7.11|Increased|C0205217|[qnco]|["Increased"-tx-23-"increased"-adj-0,"Increased"-tx-13-"increased"-verb-0]|TX|3862/9;3187/9|
00000000|MMI|7.09|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-13-"GI"-noun-0,"GI"-tx-10-"GI"-noun-0]|TX|3101/2;2816/2|
00000000|MMI|7.09|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-13-"GI"-noun-0,"Gi"-tx-10-"GI"-noun-0]|TX|3101/2;2816/2|
00000000|MMI|7.09|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-13-"GI"-noun-0,"GI"-tx-10-"GI"-noun-0]|TX|3101/2;2816/2|
00000000|MMI|7.08|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-9-"DVT"-noun-0]|TX|3465/3;2461/3|
00000000|MMI|7.08|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-9-"DVT"-noun-0]|TX|3465/3;2461/3|
00000000|MMI|7.04|Gait normal|C0231683|[fndg]|["Normal"-tx-29-"Normal"-adj-0]|TX|[4028/6],[4041/6]|
00000000|MMI|7.04|Mean Percent of Normal|C2347086|[qnco]|["% Normal"-tx-29-"Normal"-adj-0]|TX|[4028/6],[4041/6]|
00000000|MMI|7.04|Normal|C0205307|[qlco]|["NORMAL"-tx-29-"Normal"-adj-0]|TX|[4028/6],[4041/6]|
00000000|MMI|7.04|Percent normal|C0439166|[qnco]|["% normal"-tx-29-"Normal"-adj-0]|TX|[4028/6],[4041/6]|
00000000|MMI|7.04|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-9-"RESUME"-noun-0,"Resume"-tx-8-"Resume"-noun-0]|TX|2592/6;1786/6|
00000000|MMI|7.04|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-9-"RESUME"-noun-0,"Resume"-tx-8-"Resume"-noun-0]|TX|2592/6;1786/6|
00000000|MMI|7.04|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-9-"RESUME"-noun-0,"resume"-tx-8-"Resume"-noun-0]|TX|2592/6;1786/6|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-5-"CODE"-noun-0,"CODE"-tx-5-"code"-noun-0]|TX|303/4;321/4|
00000000|MMI|7.02|Last|C1517741|[qlco]|["Last"-tx-14-"last"-adj-0,"Last"-tx-11-"last"-adj-0]|TX|3216/4;2939/4|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-5-"CODE"-noun-0,"Code"-tx-5-"code"-noun-0]|TX|303/4;321/4|
00000000|MMI|7.01|Singular|C0205171|[qnco]|["SINGLE"-tx-36-"single"-adj-0,"Only"-tx-28-"only"-adv-0]|TX|4447/6;3999/4|
00000000|MMI|7.00|Primary|C0205225|[qlco]|["Primary"-tx-10-"primary"-adj-0,"Principal"-tx-9-"PRINCIPAL"-adj-0]|TX|2789/7;2148/9|
00000000|MMI|6.99|TANC2 gene|C1823227|[gngm]|["ROLSA"-tx-41-"Rolson"-noun-0,"ROLSA"-tx-9-"Rolson"-noun-0]|TX|4784/6;1842/6|
00000000|MMI|6.98|100%|C3817553|[qnco]|["100%"-tx-18-"100"-integer-0,"100%"-tx-5-"100"-integer-0]|TX|3626/3;984/3|
00000000|MMI|6.96|Recent|C0332185|[tmco]|["Recent"-tx-12-"recent"-adj-0,"Recent"-tx-10-"recent"-adj-0]|TX|2973/6;2770/6|
00000000|MMI|6.96|20%|C3842589|[fndg]|["20%"-tx-5-"20"-integer-0]|TX|[1020/2],[1053/2]|
00000000|MMI|6.95|Alert|C3665546|[ftcn]|["Alert"-tx-6-"Alert"-noun-0,"Alert"-tx-5-"Alert"-noun-0]|TX|1305/5;1065/5|
00000000|MMI|6.95|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-6-"Alert"-noun-0,"Alert"-tx-5-"Alert"-noun-0]|TX|1305/5;1065/5|
00000000|MMI|6.95|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-6-"Alert"-noun-0,"ALERT"-tx-5-"Alert"-noun-0]|TX|1305/5;1065/5|
00000000|MMI|6.94|0%|C3842591|[fndg]|["0%"-tx-5-"0"-real_number-0]|TX|[463/1],[695/1]|
00000000|MMI|6.91|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-9-"multiple"-adj-0]|TX|[2440/8],[2677/8]|
00000000|MMI|6.90|Long|C0205166|[qlco]|["Long"-tx-17-"Long"-adj-0,"Long"-tx-9-"long"-adj-0]|TX|3541/4;2639/4|
00000000|MMI|6.90|Long Variable|C1706317|[qlco]|["Long"-tx-17-"Long"-adj-0,"Long"-tx-9-"long"-adj-0]|TX|3541/4;2639/4|
00000000|MMI|6.89|Before|C0332152|[tmco]|["Prior"-tx-9-"prior"-adj-0,"Prior to"-tx-9-"prior to"-adj-0]|TX|2693/5;2693/5,2718/2|
00000000|MMI|6.88|Airway structure|C0458827|[bpoc]|["Airway"-tx-33-"airway"-noun-0,"Airway"-tx-9-"airway"-noun-0]|TX|4260/6;2721/6|
00000000|MMI|6.88|Artificial Airways|C0178987|[medd]|["Airway, NOS"-tx-33-"airway"-noun-0,"Airway, NOS"-tx-9-"airway"-noun-0]|TX|4260/6;2721/6|
00000000|MMI|6.75|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-7-"Instruction"-noun-0]|TX|1655/11|I02.903
00000000|MMI|6.61|Intubation|C0021925|[topp]|["Intubations"-tx-9-"intubations"-noun-0]|TX|2449/11|E02.585;E05.497
00000000|MMI|6.60|Nature|C0349590|[idcn]|["Nature"-tx-10-"nature"-noun-0]|TX|2822/6|K01.637
00000000|MMI|6.59|Future|C0016884|[tmco]|["Future"-tx-39-"future"-noun-0]|TX|4746/6|I01.320
00000000|MMI|5.18|Additional comments|C1830770|[fndg]|["Additional comments"-tx-41-"ADDITIONAL COMMENTS"-noun-0]|TX|4830/19|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-9-"affecting"-verb-0]|TX|2307/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-9-"ALLERGY"-noun-0]|TX|1913/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-9-"ALLERGY"-noun-0]|TX|1913/7|
00000000|MMI|5.18|Budesonide Nasal Inhaler|C1968006|[clnd]|["Budesonide Nasal Inhaler"-tx-7-"BUDESONIDE NASAL INHALER"-noun-0]|TX|1549/24|
00000000|MMI|5.18|Clear|C2963144|[qlco]|["Clear"-tx-24-"clear"-verb-0]|TX|3891/5|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-9-"Complications"-noun-0]|TX|2291/13|
00000000|MMI|5.18|Dilated|C0700124|[fndg]|["Dilated"-tx-12-"dilated"-verb-0]|TX|3073/7|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Experimental Result|C2825142|[fndg]|["Result"-tx-30-"results"-verb-0]|TX|4087/7|
00000000|MMI|5.18|Fexofenadine hydrochloride|C0771752|[orch,phsu]|["Fexofenadine HCl"-tx-7-"FEXOFENADINE HCL"-noun-0]|TX|1601/16|
00000000|MMI|5.18|Followed by|C0332283|[tmco]|["followed"-tx-38-"followed"-verb-0]|TX|4606/8|
00000000|MMI|5.18|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0]|TX|1673/10|
00000000|MMI|5.18|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0]|TX|1673/10|
00000000|MMI|5.18|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0]|TX|1673/10|
00000000|MMI|5.18|Include (action)|C2700399|[acty]|["Include"-tx-18-"include"-verb-0]|TX|3609/7|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-9-"PROCEDURES"-noun-0]|TX|2520/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-9-"affecting"-verb-0]|TX|2307/9|
00000000|MMI|5.18|July|C3829447|[qlco]|["July"-tx-9-"July"-noun-0]|TX|1874/4|
00000000|MMI|5.18|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-18-"Meds"-noun-0]|TX|3604/4|
00000000|MMI|5.18|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-16-"DM"-noun-0]|TX|3487/2|
00000000|MMI|5.18|Master of Science|C1513009|[inpr]|["M.S."-tx-43-"M."-noun-0]|TX|5032/1,5033/1|
00000000|MMI|5.18|Medical Examination|C0582103|[hlca]|["Exam"-tx-19-"exam"-noun-0]|TX|3637/4|
00000000|MMI|5.18|NITROFURANTOIN, MACROCRYSTALS|C0770666|[orch,phsu]|["Nitrofurantoin macrocrystal"-tx-9-"NITROFURANTOIN MACROCRYSTAL"-noun-0]|TX|2081/27|
00000000|MMI|5.18|Negative Surgical Margin|C1709157|[fndg]|["Clear"-tx-24-"clear"-verb-0]|TX|3891/5|
00000000|MMI|5.18|PLEC wt Allele|C4050150|[gngm]|["PCN"-tx-17-"PCN"-noun-0]|TX|3588/3|
00000000|MMI|5.18|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-5-"Pt"-noun-0]|TX|1177/2|
00000000|MMI|5.18|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-5-"Pt"-noun-0]|TX|1177/2|
00000000|MMI|5.18|Procaine hydrochloride|C0358490|[orch,phsu]|["procaine hcl"-tx-9-"PROCAINE HCL"-noun-0]|TX|2034/12|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-9-"PROCEDURES"-noun-0]|TX|2520/10|
00000000|MMI|5.18|Reaction|C0443286|[ftcn]|["Reaction"-tx-5-"reaction"-noun-0]|TX|1214/8|
00000000|MMI|5.18|Replace - HL7UpdateMode|C1554078|[idcn]|["Replace"-tx-35-"replaces"-verb-0]|TX|4402/8|
00000000|MMI|5.18|Replacement|C0559956|[ftcn]|["Replace"-tx-35-"replaces"-verb-0]|TX|4402/8|
00000000|MMI|5.18|Requirement|C1514873|[ftcn]|["Required"-tx-36-"required"-verb-0]|TX|4438/8|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-9-"ALLERGY"-noun-0]|TX|1913/7|
00000000|MMI|5.18|Result|C1274040|[ftcn]|["Result"-tx-30-"results"-verb-0]|TX|4087/7|
00000000|MMI|5.18|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-9-"scheduled"-verb-0]|TX|1901/9|
00000000|MMI|5.18|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-9-"scheduled"-verb-0]|TX|1901/9|
00000000|MMI|5.18|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-9-"scheduled"-verb-0]|TX|1901/9|
00000000|MMI|5.18|Scientific Study|C0947630|[lbpr]|["studies"-tx-41-"studies"-verb-0]|TX|4822/7|
00000000|MMI|5.18|Sigmoidostomy|C0192964|[topp]|["Colostomy, sigmoid"-tx-16-"sigmoid colostomy"-noun-0]|TX|3522/17|
00000000|MMI|5.18|What subject filter - Result|C1546471|[idcn]|["Result"-tx-30-"results"-verb-0]|TX|4087/7|
00000000|MMI|5.18|Wheat gluten|C3812405|[aapp,phsu]|["Wheat gluten"-tx-9-"WHEAT/GLUTEN"-noun-0]|TX|2066/12|
00000000|MMI|5.18|Wheat gluten extract|C2827346|[aapp,phsu]|["WHEAT GLUTEN"-tx-9-"WHEAT/GLUTEN"-noun-0]|TX|2066/12|
00000000|MMI|5.18|include - SetOperator|C1552866|[idcn]|["include"-tx-18-"include"-verb-0]|TX|3609/7|
00000000|MMI|5.18|m/s|C0439493|[qnco]|["m/s"-tx-43-"M."-noun-0]|TX|5032/1,5033/1|
00000000|MMI|5.18|replaces - ActRelationshipType|C1550539|[idcn]|["replaces"-tx-35-"replaces"-verb-0]|TX|4402/8|
00000000|MMI|5.18|replaces - RoleLinkType|C1553396|[idcn]|["replaces"-tx-35-"replaces"-verb-0]|TX|4402/8|
00000000|MMI|5.18|sulfa|C0749139|[phsu]|["sulfa"-tx-9-"Sulfa"-noun-0]|TX|1936/5|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-9-"TREATMENTS/PROCEDURES"-noun-0]|TX|2543/21|
00000000|MMI|3.98|Appearance|C0700364|[qlco]|["APPEAR"-tx-15-"appeared"-verb-0]|TX|3390/8|
00000000|MMI|3.98|Show|C1547282|[anim]|["Show"-tx-12-"showed"-verb-0]|TX|3044/6|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-5-"DISCHARGE MEDICATIONS"-noun-0]|TX|344/21|
00000000|MMI|3.75|digoxin dose|C0366448|[clna]|["digoxin doses"-tx-5-"digoxin doses"-noun-0]|TX|735/13|
00000000|MMI|3.74|Intestine Pain Adverse Event|C1557475|[fndg]|["Bowel pain"-tx-10-"bowel pain"-noun-0]|TX|2835/5,2865/4|
00000000|MMI|3.74|intestinal pain|C0850045|[sosy]|["Bowel pain"-tx-10-"bowel pain"-noun-0]|TX|2835/5,2865/4|
00000000|MMI|3.70|Abnormal breathing|C1260922|[fndg]|["breathing condition"-tx-41-"breathing CONDITION"-noun-0]|TX|4919/9,4939/9|
00000000|MMI|3.68|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Active|C0205177|[ftcn]|["Activity"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Activities|C0441655|[acty]|["ACTIVITY"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-8-"ACTIVITY"-noun-1]|TX|1776/8|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-3-"Attending"-noun-0]|TX|266/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-3-"Attending"-noun-0]|TX|266/9|
00000000|MMI|3.68|Coating (film)|C1522408|[qlco]|["Coated"-tx-5-"COATED"-adj-0]|TX|391/6|
00000000|MMI|3.68|Enteral|C1304890|[spco]|["Enteric"-tx-5-"ENTERIC"-adj-0]|TX|383/7|
00000000|MMI|3.68|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Nuclear cap binding complex location|C2263086|[celc]|["CBC"-tx-29-"CBC"-noun-0]|TX|4035/3|
00000000|MMI|3.68|Percent Activity|C0439167|[qnco]|["% Activity"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-8-"ACTIVITY"-noun-0]|TX|1776/8|
00000000|MMI|3.68|Respiratory Domain|C2986904|[idcn]|["RE"-tx-39-"re"-verb-0]|TX|4715/2|
00000000|MMI|3.68|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-39-"re"-verb-0]|TX|4715/2|
00000000|MMI|3.68|Weekly|C0332174|[tmco]|["/week"-tx-14-"week"-noun-0]|TX|3221/4|
00000000|MMI|3.68|week|C0439230|[tmco]|["WEEK"-tx-14-"week"-noun-0]|TX|3221/4|
00000000|MMI|3.67|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-9-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2148/9,2168/9|
00000000|MMI|3.67|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-9-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2148/9,2168/9|
00000000|MMI|3.65|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-9-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2158/19|
00000000|MMI|3.64|Able (finding)|C1299581|[fndg]|["Able"-tx-20-"able"-adj-0]|TX|3710/4|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-41-"ENTERED"-verb-0]|TX|4989/7|
00000000|MMI|3.63|Axial R|C3538806|[spco]|["Ra"-tx-19-"ra"-noun-0]|TX|3660/2|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-5-"DISPOSITION"-noun-0]|TX|326/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-5-"DISPOSITION"-noun-0]|TX|326/11|
00000000|MMI|3.63|HP gene|C1415692|[gngm]|["Bp"-tx-19-"bp"-noun-0]|TX|3665/2|
00000000|MMI|3.63|HP wt Allele|C1708288|[gngm]|["BP"-tx-19-"bp"-noun-0]|TX|3665/2|
00000000|MMI|3.63|Institution (social concept)|C1272753|[idcn]|["Institute"-tx-39-"instituting"-verb-0]|TX|4718/11|
00000000|MMI|3.63|Right arm|C4048756|[bpoc]|["RA"-tx-19-"ra"-noun-0]|TX|3660/2|
00000000|MMI|3.62|Irregular heart beat|C0237314|[fndg]|["Irregular heart rate"-tx-25-"Irregular heart rate"-noun-0]|TX|3898/20|
00000000|MMI|3.61|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-3-"Service"-noun-0]|TX|133/7|
00000000|MMI|3.61|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-16-"MI"-noun-0]|TX|3513/2|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-41-"PLAN"-noun-0]|TX|4963/4|
00000000|MMI|3.61|Services|C0557854|[ocac]|["Service"-tx-3-"Service"-noun-0]|TX|133/7|
00000000|MMI|3.61|Software Service|C2825316|[mnob]|["Service"-tx-3-"Service"-noun-0]|TX|133/7|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-41-"PLAN"-noun-0]|TX|4963/4|
00000000|MMI|3.61|Treated with|C0332293|[topp]|["Treated with"-tx-34-"treated with"-verb-0]|TX|4288/12|
00000000|MMI|3.60|Allegra|C1110594|[orch,phsu]|["Allegra"-tx-7-"ALLEGRA"-noun-0]|TX|1591/7|
00000000|MMI|3.60|Basal Diet|C2983588|[food]|["DIET"-tx-8-"DIET"-noun-0]|TX|1754/4|
00000000|MMI|3.60|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|1754/4|
00000000|MMI|3.60|Filter (function)|C1704449|[cnce]|["Filter"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|Filter - medical device|C1875155|[medd]|["FILTER"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|Filter Device Component|C1704684|[mnob]|["Filter"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|Filters|C0180860|[mnob]|["Filter"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|Optical filter|C0581406|[medd]|["Filter"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-8-"DIET"-noun-0]|TX|1754/4|
00000000|MMI|3.60|Wednesday|C0585027|[tmco]|["Wednesday"-tx-9-"Wednesday"-noun-0]|TX|1862/9|
00000000|MMI|3.60|filter information process|C1522664|[inpr]|["Filter"-tx-16-"filter"-noun-0]|TX|3477/6|
00000000|MMI|3.60|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-9-"H/O"-noun-0]|TX|2385/3|
00000000|MMI|3.60|Allergy to sulfonamides|C0038757|[dsyn]|["allergy sulfa"-tx-5-"allergy Sulfa"-noun-0]|TX|1196/7,1207/5|
00000000|MMI|3.59|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-5-"Instructions"-noun-0]|TX|711/12|
00000000|MMI|3.59|Ability to Sit question|C4050224|[inpr]|["Sitting"-tx-20-"sitting"-noun-0]|TX|3685/7|
00000000|MMI|3.59|Base|C0178499|[chvf]|["bases"-tx-26-"bases"-noun-0]|TX|3959/5|
00000000|MMI|3.59|Basilar Rales|C0240859|[fndg]|["Crackles"-tx-26-"crackles"-verb-0]|TX|3947/8|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-44-"END"-noun-0]|TX|5072/3|
00000000|MMI|3.59|Pharmaceutical Preparations|C0013227|[phsu]|["Medication"-tx-14-"medication"-noun-0]|TX|3270/10|D26
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-9-"Responsible"-adj-0]|TX|2179/11|
00000000|MMI|3.59|Sitting Function|C2584297|[phsf]|["Sitting"-tx-20-"sitting"-noun-0]|TX|3685/7|
00000000|MMI|3.59|Sitting position|C0277814|[fndg]|["SITTING"-tx-20-"sitting"-noun-0]|TX|3685/7|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-44-"END"-noun-0]|TX|5072/3|
00000000|MMI|3.59|Unit dose - Base|C1626935|[qnco]|["Bases"-tx-26-"bases"-noun-0]|TX|3959/5|
00000000|MMI|3.59|consideration|C0518609|[fndg]|["Consideration"-tx-39-"consideration"-noun-0]|TX|4698/13|
00000000|MMI|3.59|medication - HL7 publishing domain|C3244316|[ftcn]|["medication"-tx-14-"medication"-noun-0]|TX|3270/10|
00000000|MMI|3.57|upper lip swelling|C0240212|[fndg]|["LIP SWELLING, UPPER"-tx-21-"upper lip swelling"-noun-0]|TX|3768/18|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-3-"CONTINGENT"-noun-0]|TX|188/10|
00000000|MMI|3.57|Furosemide:Mass:Pt:Dose:Qn|C0366492|[clna]|["Furosemide Dose"-tx-36-"dose lasix"-noun-0]|TX|4454/4,4465/5|
00000000|MMI|3.57|List|C0745732|[cnce]|["List"-tx-17-"list"-noun-0]|TX|3546/4|
00000000|MMI|3.57|Maintaining (action)|C1314677|[ftcn]|["Maintained"-tx-11-"maintained"-verb-0]|TX|2880/10|
00000000|MMI|3.57|Negation|C1518422|[ftcn]|["Not"-tx-9-"NOT"-adv-0]|TX|2567/3|
00000000|MMI|3.57|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-15-"worsening"-noun-0]|TX|3405/9|
00000000|MMI|3.57|Presentation|C0449450|[idcn]|["Presenting"-tx-32-"presenting"-verb-0]|TX|4175/10|
00000000|MMI|3.57|R prime|C2603358|[clna]|["R'"-tx-9-"R"-noun-0]|TX|2576/1|
00000000|MMI|3.57|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-41-"return"-noun-0]|TX|4851/6|
00000000|MMI|3.57|Right|C0205090|[spco]|["R-"-tx-9-"R"-noun-0]|TX|2576/1|
00000000|MMI|3.57|Sequence Data Type|C3272378|[inpr]|["LIST"-tx-17-"list"-noun-0]|TX|3546/4|
00000000|MMI|3.57|Worse|C1457868|[fndg]|["Worsening"-tx-15-"worsening"-noun-0]|TX|3405/9|
00000000|MMI|3.57|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-15-"worsening"-noun-0]|TX|3405/9|
00000000|MMI|3.56|Clouded consciousness|C0683369|[sosy]|["Muddled"-tx-20-"muddled"-adj-0]|TX|3738/7|
00000000|MMI|3.56|Does speak|C0600116|[fndg]|["speak"-tx-20-"speak"-verb-0]|TX|3718/5|
00000000|MMI|3.56|Slight (qualifier value)|C2937276|[qlco]|["Slightly"-tx-20-"slightly"-adv-0]|TX|3729/8|
00000000|MMI|3.56|Slightly (qualifier value)|C0750482|[qlco]|["Slightly"-tx-20-"slightly"-adv-0]|TX|3729/8|
00000000|MMI|3.56|Speak - language ability|C1547187|[idcn]|["Speak"-tx-20-"speak"-verb-0]|TX|3718/5|
00000000|MMI|3.56|Speaking (activity)|C0234856|[dora]|["Speak"-tx-20-"speak"-verb-0]|TX|3718/5|
00000000|MMI|3.55|Aspects of signs|C0220912|[ftcn]|["signs"-tx-37-"signs"-noun-0]|TX|4566/5|
00000000|MMI|3.55|Attack behavior|C1261512|[socb]|["attack"-tx-13-"attack"-noun-0]|TX|3160/6|
00000000|MMI|3.55|Improvement|C2986411|[cnce]|["Improvement"-tx-37-"improvement"-noun-0]|TX|4529/11|
00000000|MMI|3.55|Manufactured sign|C0220913|[mnob]|["signs"-tx-37-"signs"-noun-0]|TX|4566/5|
00000000|MMI|3.55|Observation of attack|C1304680|[fndg]|["Attack"-tx-13-"attack"-noun-0]|TX|3160/6|
00000000|MMI|3.55|Onset of illness|C0277793|[tmco]|["Attack"-tx-13-"attack"-noun-0]|TX|3160/6|
00000000|MMI|3.55|Physical findings|C0311392|[fndg]|["SIGNS"-tx-37-"signs"-noun-1]|TX|4566/5|
00000000|MMI|3.55|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-13-"likely"-adv-0]|TX|3132/6|
00000000|MMI|3.55|Probably|C0750492|[idcn]|["Likely"-tx-13-"likely"-adv-0]|TX|3132/6|
00000000|MMI|3.55|Service Request Relationship - Tapering|C1548969|[idcn]|["Tapering"-tx-14-"tapering"-noun-0]|TX|3256/8|
00000000|MMI|3.55|Tapering - action|C0441640|[hlca]|["Tapering"-tx-14-"tapering"-noun-0]|TX|3256/8|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-3-"USED"-verb-1]|TX|237/4|
00000000|MMI|3.55|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-28-"Labs"-noun-0]|TX|3983/4|
00000000|MMI|3.55|Observation - diagnostic procedure|C1964257|[diap]|["OBSERVATION"-tx-33-"observation"-noun-0]|TX|4237/11|
00000000|MMI|3.54|HPX wt Allele|C3814444|[gngm]|["HX"-tx-9-"hx"-noun-0]|TX|2644/2|
00000000|MMI|3.54|Medical History|C0262926|[fndg]|["Hx"-tx-9-"hx"-noun-0]|TX|2644/2|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-3-"D/C"-noun-1]|TX|224/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-3-"D/C"-noun-0]|TX|224/3|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-9-"Causing"-adj-0]|TX|2207/7|
00000000|MMI|3.50|Primary operation|C0439631|[topp]|["Primary"-tx-10-"primary"-adj-0]|TX|2789/7|
00000000|MMI|3.50|True primary (qualifier value)|C0439612|[tmco]|["Primary"-tx-10-"primary"-adj-0]|TX|2789/7|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-3-"YES"-noun-0]|TX|262/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-3-"YES"-noun-0]|TX|262/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-41-"dictated"-adj-0]|TX|4972/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-41-"dictated"-adj-0]|TX|4972/8|
00000000|MMI|3.48|Stricture of colon|C0267466|[dsyn]|["colonic strictures"-tx-16-"colonic strictures"-noun-0]|TX|3444/18|
00000000|MMI|3.48|Restricted|C0443288|[ftcn]|["Restriction"-tx-8-"Restrictions"-noun-0]|TX|1763/12|
00000000|MMI|3.48|Alternating|C0332270|[ftcn]|["alternate"-tx-5-"alternate"-adj-0]|TX|725/9|
00000000|MMI|3.48|Alternative|C1523987|[cnce]|["Alternate"-tx-5-"alternate"-adj-0]|TX|725/9|
00000000|MMI|3.48|Apyrexial|C0277797|[fndg]|["Afebrile"-tx-19-"afebrile"-adj-0]|TX|3646/8|
00000000|MMI|3.48|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-8-"FOLLOW UP"-adj-0]|TX|1810/9|
00000000|MMI|3.48|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-8-"FOLLOW UP"-adj-0]|TX|1810/9|
00000000|MMI|3.48|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-8-"FOLLOW UP"-adj-1]|TX|1810/9|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-5-"Full"-adj-0]|TX|316/4|
00000000|MMI|3.48|Home environment|C0442519|[cnce]|["HOME"-tx-5-"Home"-noun-0]|TX|339/4|
00000000|MMI|3.48|Impression|C1998467|[qlco]|["Impression"-tx-31-"Impression"-noun-0]|TX|4108/10|
00000000|MMI|3.48|Radiologic Impression|C4049863|[fndg]|["Impression"-tx-31-"Impression"-noun-0]|TX|4108/10|
00000000|MMI|3.48|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-8-"regular exercise"-noun-0]|TX|1793/16|
00000000|MMI|3.48|follow-up|C1522577|[hlca]|["Follow Up"-tx-8-"FOLLOW UP"-adj-0]|TX|1810/9|
00000000|MMI|3.48|impression (attitude)|C0596764|[inbe]|["impression"-tx-31-"Impression"-noun-0]|TX|4108/10|
00000000|MMI|3.48|persistent|C0205322|[tmco]|["Persistent"-tx-13-"persistent"-adj-0]|TX|3090/10|
00000000|MMI|3.47|mg/mg|C1319635|[qnco]|["mg/mg"-tx-5-"MG MG"-noun-0]|TX|403/2,424/2|
00000000|MMI|3.47|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-16-"CAD"-adj-0]|TX|3505/3|
00000000|MMI|3.47|Has difficulty doing (qualifier value)|C1299586|[fndg]|["Difficulty"-tx-41-"difficulty"-noun-0]|TX|4908/10|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-41-"Stable"-adj-0]|TX|4950/6|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-41-"Stable"-adj-0]|TX|4950/6|
00000000|MMI|3.46|1+|C3816745|[fndg]|["1+"-tx-7-"1"-integer-0]|TX|1576/1|
00000000|MMI|3.46|1+ Score|C2827734|[qnco]|["1+"-tx-7-"1"-integer-0]|TX|1576/1|
00000000|MMI|3.46|1+ Score, WHO|C2981698|[clas]|["1+"-tx-7-"1"-integer-0]|TX|1576/1|
00000000|MMI|3.46|No Application Type|C1546968|[idcn]|["NA"-tx-7-"NA"-noun-0]|TX|1584/2|
00000000|MMI|3.46|Sodium Cation|C0597484|[elii]|["Na+"-tx-7-"NA"-noun-0]|TX|1584/2|
00000000|MMI|3.46|Spray (action)|C2003858|[ftcn]|["Spray"-tx-7-"SPRAY"-noun-0]|TX|1578/5|
00000000|MMI|3.46|Spray Dosing Unit|C1704413|[qnco]|["{Spray}"-tx-7-"SPRAY"-noun-0]|TX|1578/5|
00000000|MMI|3.46|Teaching principal|C0401925|[prog]|["Principal"-tx-9-"PRINCIPAL"-adj-0]|TX|2148/9|
00000000|MMI|3.46|50%|C3842586|[fndg]|["50%"-tx-6-"50"-integer-0]|TX|1292/2|
00000000|MMI|3.46|<50|C3843766|[fndg]|["<50"-tx-6-"50"-integer-0]|TX|1292/2|
00000000|MMI|3.46|C2 - answer to question|C3810846|[fndg]|["C2"-tx-30-"c2"-noun-0]|TX|4062/2|
00000000|MMI|3.46|microgram|C0439211|[qnco]|["mcg"-tx-6-"MCG"-noun-0]|TX|1295/3|
00000000|MMI|3.46|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-6-"MCG"-noun-0]|TX|1295/3|
00000000|MMI|3.45|Total abdominal hysterectomy|C0404079|[topp]|["tah"-tx-9-"TAH"-noun-0]|TX|2417/3|
00000000|MMI|3.45|60%|C3842585|[fndg]|["60%"-tx-7-"60"-integer-0]|TX|1620/2|
00000000|MMI|3.45|48 Hours|C1442464|[tmco]|["48 Hours"-tx-37-"48 hours"-noun-0]|TX|4549/8|
00000000|MMI|3.45|48 hour time frame|C0439586|[tmco]|["48 hours"-tx-37-"48 hours"-noun-0]|TX|4549/8|
00000000|MMI|3.45|Airway Compromise|C4055482|[fndg]|["Airway Compromise"-tx-37-"airway compromise"-noun-1]|TX|4575/17|
00000000|MMI|3.45|Natures|C1262865|[ftcn]|["Nature"-tx-10-"nature"-noun-0]|TX|2822/6|
00000000|MMI|3.45|Administration procedure|C1533734|[topp]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|
00000000|MMI|3.45|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-9-"ASA"-noun-0]|TX|2373/3|
00000000|MMI|3.45|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|
00000000|MMI|3.45|LoDose|C0126119|[orch,phsu]|["LoDose"-tx-9-"lodose"-noun-0]|TX|2361/6|
00000000|MMI|3.45|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|E02
00000000|MMI|3.45|Treating|C1522326|[ftcn]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|
00000000|MMI|3.45|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-9-"Treatment"-noun-0]|TX|2317/9|
00000000|MMI|3.45|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-9-"Treatment"-noun-0]|TX|2317/9|
00000000|MMI|3.45|Left to right|C0439757|[ftcn]|["Left to Right side"-tx-21-"Left to right side"-noun-0]|TX|3763/4,3787/2,3811/10|
00000000|MMI|3.44|TDGF1P2 gene|C3469967|[gngm]|["CR-2"-tx-28-"Cr 2"-noun-0]|TX|4008/2,4013/1|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-3-"CAR"-noun-0]|TX|142/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-3-"CAR"-noun-0]|TX|142/3|
00000000|MMI|3.44|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-15-"ED"-noun-0]|TX|3422/2|
00000000|MMI|3.44|Hospital environment|C1510665|[qlco]|["Hospital"-tx-41-"hospital"-noun-0]|TX|4865/8|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-3-"CAR"-noun-0]|TX|142/3|
00000000|MMI|3.44|Outpatient elective|C1549492|[idcn]|["Outpatient elective"-tx-12-"outpatient elective"-noun-0]|TX|3001/19|
00000000|MMI|3.43|Possible|C0332149|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|1187/8|
00000000|MMI|3.43|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|1187/8|
00000000|MMI|3.43|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|1187/8|
00000000|MMI|3.43|Normal size|C0332506|[qnco]|["Normal size"-tx-21-"size normal"-noun-0]|TX|3796/4,3804/6|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-9-"BRIEF"-adj-0]|TX|2586/5|
00000000|MMI|3.43|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-36-"I"-noun-0]|TX|4483/1|
00000000|MMI|3.43|Brief|C1879313|[tmco]|["Brief"-tx-9-"BRIEF"-adj-0]|TX|2586/5|
00000000|MMI|3.43|Infusion procedures|C0574032|[topp]|["Infusion"-tx-36-"infusion"-noun-0]|TX|4505/8|
00000000|MMI|3.43|Infusion route|C1827465|[ftcn]|["Infusion"-tx-36-"infusion"-noun-0]|TX|4505/8|
00000000|MMI|3.43|Rapid|C0456962|[qlco]|["Rapid"-tx-37-"rapid"-adj-0]|TX|4523/5|
00000000|MMI|3.43|Shortened|C1282927|[qlco]|["brief"-tx-9-"BRIEF"-adj-0]|TX|2586/5|
00000000|MMI|3.43|U/day|C0456683|[qnco]|["U/day"-tx-41-"days u"-noun-0]|TX|4796/4,4803/1|
00000000|MMI|3.42|Case (situation)|C0868928|[ftcn]|["Case"-tx-33-"case"-prep-0]|TX|4252/4|
00000000|MMI|3.42|Clinical Study Case|C1706256|[cnce]|["Case"-tx-33-"case"-prep-0]|TX|4252/4|
00000000|MMI|3.42|Instability|C1444783|[fndg]|["Instability"-tx-33-"instability"-noun-0]|TX|4267/11|
00000000|MMI|3.42|LRRC4B gene|C1537594|[gngm]|["HSM"-tx-25-"HSM"-noun-0]|TX|3928/3|
00000000|MMI|3.42|Only - dosing instruction fragment|C1720467|[inpr]|["Only"-tx-28-"only"-adv-0]|TX|3999/4|
00000000|MMI|3.42|Packaging Case|C1706255|[medd]|["CASE"-tx-33-"case"-prep-0]|TX|4252/4|
00000000|MMI|3.42|Place|C0442504|[spco]|["Place"-tx-9-"place"-noun-0]|TX|2481/5|
00000000|MMI|3.42|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-9-"place"-noun-0]|TX|2481/5|
00000000|MMI|3.42|Upper|C1282910|[spco]|["UPPER"-tx-15-"upper"-noun-0]|TX|3344/5|
00000000|MMI|3.42|day|C0439228|[tmco]|["DAY"-tx-15-"day"-noun-0]|TX|3366/3|
00000000|MMI|3.42|per day|C0439505|[tmco]|["/day"-tx-15-"day"-noun-0]|TX|3366/3|
00000000|MMI|3.42|put - instruction imperative|C1882509|[acty]|["Place"-tx-9-"place"-noun-0]|TX|2481/5|
00000000|MMI|3.42|Consent Type - Colonoscopy|C1548837|[hlca]|["Colonoscopy"-tx-12-"colonoscopy"-noun-0]|TX|3021/11|
00000000|MMI|3.42|Groups|C0441833|[idcn]|["Panel"-tx-41-"panel"-noun-0]|TX|4816/5|
00000000|MMI|3.42|Laboratory Order Panels|C1999270|[inpr]|["Panel"-tx-41-"panel"-noun-0]|TX|4816/5|
00000000|MMI|3.42|Panel Device Component|C3537156|[mnob]|["Panel"-tx-41-"panel"-noun-0]|TX|4816/5|
00000000|MMI|3.42|Distant|C0443203|[spco]|["Remote"-tx-9-"remote"-adj-0]|TX|2686/6|
00000000|MMI|3.42|Due|C3146286|[idcn]|["Due"-tx-9-"due"-prep-0]|TX|2714/3|
00000000|MMI|3.42|Edema:Finding:P